CEO Dr. Jack Regan joined Steve Darling from Proactive Investors to share news the company will be approaching Government and showing the effectiveness and speed of their MiQLab ™ in detecting plague.
BioThreat Detection
LexaGene’s MiQLab System drastically shortens the time gap between pathogen identification enabling an organization to maximize containment efforts and minimize the impact on food, water, and people.
Point of Need Diagnostics for Effective Pathogen Monitoring
Rapid Biothreat Detection within hours instead of days enabling improved preparedness improving food, water, and human safety.
Customizable: Detect up to 27 Targets of Interest from a single sample using a fully integrated sample-to-answer system that provides easy to interpret results.
Easy to Use Open-Access Feature enables assay deployment within weeks and hands on time of less than one minute as compared to closed-access systems.
LexaGene is a molecular diagnostics company that has commercialized the MiQLab System for fast and easy detection of biological contaminants, pathogens and other molecular markers.
LexaGene’s MiQLab™ System is the only fully automated system on the market today that is equipped with a disposable filter-based sample preparation cartridge that allows for efficient processing of large volumes of sample for sensitive detection of contaminants.
This spring LexaGene conducted a market research survey in conjunction with AAHA to assess the opinions of practicing veterinarians on AMR stewardship and the use of antibiotics in the treatment of companion animals.
The most menacing of all resistant bacteria are the so called “super bugs”- strains of bacteria that are resistant to several different classes of antibiotics or multidrug resistant.
LexaGene’s MiQLab™ System, a TRL-7 technology, drastically shortens the time gap between novel pathogen identification and point-of-need testing through its open-access feature.
